Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Yerly, S. Jost, A. Telenti, M. Flepp, L. Kaiser, J. Chave, P. Vernazza, M. Battegay, H. Furrer, B. Chanzy, P. Burgisser, M. Rickenbach, M. Gebhardt, Marie‐Charlotte Bernard, T. Perneger, B. Hirschel, L. Perrin (2003)
Infrequent Transmission of HIV-1 Drug-Resistant VariantsAntiviral Therapy, 9
B. Brenner, M. Wainberg, H. Salomón, D. Rouleau, A. Dascal, B. Spira, R. Sekaly, B. Conway, J. Routy (2000)
Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection Study.International journal of antimicrobial agents, 16 4
S. Little, S. Holte, J. Routy, E. Daar, M. Markowitz, A. Collier, R. Koup, J. Mellors, E. Connick, B. Conway, M. Kilby, Lei Wang, J. Whitcomb, N. Hellmann, D. Richman (2002)
Antiretroviral-drug resistance among patients recently infected with HIV.The New England journal of medicine, 347 6
J. Barbour, T. Wrin, R. Grant, Jeffrey Martin, M. Segal, C. Petropoulos, S. Deeks (2002)
Evolution of Phenotypic Drug Susceptibility and Viral Replication Capacity during Long-Term Virologic Failure of Protease Inhibitor Therapy in Human Immunodeficiency Virus-Infected AdultsJournal of Virology, 76
M. Chaix, D. Descamps, M. Harzic, V. Schneider, C. Deveau, C. Tamalet, I. Pellegrin, J. Izopet, A. Ruffault, B. Masquelier, L. Meyer, C. Rouzioux, F. Brun-vezinet, D. Costagliola (2003)
Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in FranceAIDS, 17
G. Lucas, R. Chaisson, R. Moore (1999)
Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug ReactionsAnnals of Internal Medicine, 131
B. Gutsche (2005)
Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral TherapySurvey of Anesthesiology, 49
MD Hammer (2006)
Treatment for Adult HIV Infection 2006 Recommendations of the International AIDS Society–USA Panel
R. Grant, F. Hecht, M. Warmerdam, Lea Liu, T. Liegler, C. Petropoulos, N. Hellmann, M. Chesney, M. Busch, J. Kahn (2002)
Time trends in primary HIV-1 drug resistance among recently infected persons.JAMA, 288 2
D. Bezemer, S. Jurriaans, M. Prins, L. Hoek, J. Prins, F. Wolf, B. Berkhout, R. Coutinho, N. Back (2004)
Declining trend in transmission of drug-resistant HIV-1 in AmsterdamAIDS, 18
H. Devereux, M. Youle, Margaret Johnson, C. Loveday (1999)
Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.AIDS, 13 18
D. Ahlgren (1996)
Role of primary infection in epidemics of HIV in gay cohorts.Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 11 2
D. Boden, A. Hurley, Linqi Zhang, Yun-zhen Cao, Yong Guo, E.A. Jones, John Tsay, J. Ip, C. Farthing, K. Limoli, N. Parkin, M. Markowitz (1999)
HIV-1 drug resistance in newly infected individuals.JAMA, 282 12
P. Yeni, S. Hammer, M. Hirsch, M. Saag, M. Schechter (2004)
Treatment for adult HIV infection.JAMA, 292
Miller, A. Vandamme, C. Loveday, S. Staszewski, J. Lundgren, M. Youle, M. Ait‐Khaled, C. Boucher, F. Brun-vezinet, N. Dedes, C. Giaquinto, K. Hertogs, F. Houÿez, L. Perrin, D. Pillay, J. Schmit, R. Schuurman, J. Lange (2001)
Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European settingAIDS, 15
R. Veazey, M. Demaria, L. Chalifoux, D. Shvetz, D. Pauley, H. Knight, M. Rosenzweig, R. Johnson, R. Desrosiers, A. Lackner (1998)
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.Science, 280 5362
J. Durant, P. Clevenbergh, P. Halfon, P. Delgiudice, S. Porsin, P. Simonet, N. Montagne, C. Boucher, J. Schapiro, P. Dellamonica (1999)
Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trialThe Lancet, 353
Little SJ
Longitudinal analysis of transmitted drug resistance among recently HIV-infected subjects in North America.
Stephen Taylor, P. Cane, S. Hué, Li Xu, T. Wrin, Y. Lie, N. Hellmann, C. Petropoulos, J. Workman, D. Ratcliffe, B. Choudhury, D. Pillay (2003)
Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations.AIDS research and human retroviruses, 19 5
J Jackson, Scott Barnett, E. Piwowar-Manning, L. Apuzzo, C. Raines, C. Hendrix, F. Hamzeh, J. Gallant (2003)
A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high riskAIDS, 17
A. Mocroft, H. Devereux, S. Kinloch-de-Loes, Deborah Wilson, S. Madge, M. Youle, M. Tyrer, C. Loveday, A. Phillips, Margaret Johnson (2000)
Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic populationAIDS, 14
M. Nijhuis, R. Schuurman, D. Jong, John Erickson, E. Gustchina, J. Albert, P. Schipper, S. Gulnik, C. Boucher (1999)
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.AIDS, 13 17
B. Brenner, J. Routy, M. Petrella, D. Moisi, Maureen Oliveira, M. Detorio, B. Spira, Vidal Essabag, B. Conway, R. Lalonde, R. Sékaly, M. Wainberg (2002)
Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary InfectionJournal of Virology, 76
A. ronde, M. Dooren, L. Hoek, Denise Bouwhuis, E. Rooij, B. Gemen, R. Boer, J. Goudsmit (2001)
Establishment of New Transmissible and Drug-Sensitive Human Immunodeficiency Virus Type 1 Wild Types due to Transmission of Nucleoside Analogue-Resistant VirusJournal of Virology, 75
E. Daar, T. Moudgil, R. Meyer, D. Ho (1991)
Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.The New England journal of medicine, 324 14
J. Baxter, D. Mayers, D. Wentworth, J. Neaton, M. Hoover, M. Winters, S. Mannheimer, M. Thompson, D. Abrams, Barbara Brizz, J. Ioannidis, T. Merigan (2000)
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapyAIDS, 14
J. Barbour, F. Hecht, T. Wrin, T. Liegler, C. Ramstead, M. Busch, M. Segal, C. Petropoulos, R. Grant (2004)
Persistence of primary drug resistance among recently HIV-1 infected adultsAIDS, 18
M. Hirsch, F. Brun-vezinet, B. Clotet, B. Conway, D. Kuritzkes, R. D’Aquila, L. Demeter, S. Hammer, V. Johnson, C. Loveday, J. Mellors, D. Jacobsen, D. Richman (2003)
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37 1
P. Narciso, S. Galgani, B. Grosso, M. Marco, A. Santis, P. Balestra, V. Ciapparoni, V. Tozzi (2001)
Acute disseminated encephalomyelitis as manifestation of primary HIV infectionNeurology, 57
B. Tindall, L. Evans, P. Cunningham, P. McQueen, L. Hurren, E. Vasak, J. Mooney, D. Cooper (1992)
Identification of HIV‐1 in semen following primary HIV‐1 infectionAIDS, 6
V. Miller, C. Sabin, K. Hertogs, S. Bloor, J. Martinez-Picado, R. D’Aquila, B. Larder, T. Lutz, P. Gute, E. Weidmann, H. Rabenau, A. Phillips, S. Staszewski (2000)
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failureAIDS, 14
J. Martinez-Picado, A. Savara, L. Sutton, R. D’Aquila (1999)
Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1Journal of Virology, 73
Salomon H
Primary infection study. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use.
V. Simon, J. Vanderhoeven, A. Hurley, B. Ramratnam, M. Louie, Keith Dawson, N. Parkin, D. Boden, M. Markowitz (2002)
Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individualsAIDS, 16
F. Hecht, R. Grant, C. Petropoulos, Beth Dillon, M. Chesney, H. Tian, N. Hellmann, Nirmala Bandrapalli, L. Digilio, B. Branson, J. Kahn (1998)
Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.The New England journal of medicine, 339 5
K. Porter, D. Pillay, P. Cane, G. Dean, D. Churchill, G. Baily, S. Drake, M. Fisher (2001)
Analysis of prevalence of HIV-1 drug resistance in primary infections in the United KingdomBMJ : British Medical Journal, 322
D. Richman, S. Morton, T. Wrin, N. Hellmann, S. Berry, M. Shapiro, S. Bozzette (2004)
The prevalence of antiretroviral drug resistance in the United StatesAIDS, 18
Mocroft A
Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Center for HIV Medicine.
C. Delaugerre, L. Morand‐Joubert, M. Chaix, O. Picard, A. Marcelin, V. Schneider, A. Krivine, A. Compagnucci, C. Katlama, P. Girard, V. Calvez (2003)
Persistence of Multidrug-Resistant HIV-1 without Antiretroviral Treatment 2 Years after Sexual TransmissionAntiviral Therapy, 9
C. Cunningham, M. Chaix, C. Rekacewicz, P. Britto, C. Rouzioux, R. Gelber, A. Dorenbaum, J. Delfraissy, B. Bazin, L. Mofenson, J. Sullivan (2002)
Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316.The Journal of infectious diseases, 186 2
S. Pinkerton, Jeffrey Martin, M. Roland, M. Katz, T. Coates, J. Kahn (2004)
Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.Archives of internal medicine, 164 1
T. Quinn, M. Wawer, N. Sewankambo, D. Serwadda, Chuanjun Li, Fredrick Wabwire‐Mangen, M. Meehan, T. Lutalo, Ronald Gray (2000)
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.The New England journal of medicine, 342 13
S. Yerly, L. Kaiser, E. Race, J. Bru, F. Clavel, L. Perrin (1999)
Transmission of antiretroviral-drug-resistant HIV-1 variantsThe Lancet, 354
R. D’Aquila, J. Schapiro, F. Brun-vezinet, B. Clotet, B. Conway, L. Demeter, R. Grant, V. Johnson, D. Kuritzkes, C. Loveday, R. Shafer, D. Richman (2003)
Drug resistance mutations in HIV-1.Topics in HIV medicine : a publication of the International AIDS Society, USA, 11 3
H. Salomón, M. Wainberg, B. Brenner, Y. Quan, D. Rouleau, P. Cote, R. Leblanc, E. Lefebvre, B. Spira, C. Tsoukas, R. Sekaly, B. Conway, D. Mayers, J. Routy (2000)
Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug useAIDS, 14
The transmission of drug-resistant HIV-1 (primary HIV resistance) is a cause of growing concern. The prevalence of drug-resistant variants in patients with primary HIV-1 infection (PHI) ranges from 10 to 36%. Unlike patients with secondary resistance, patients with primary HIV resistance do not show a rapid conversion to wild-type drug-sensitive virus in the absence of treatment. Moreover, primary HIV-1 resistance is associated with higher rates of treatment failure. Rapid diagnosis is important, since early events in PHI may have a critical role in disease progression. An early diagnosis is also essential to prevent HIV-1 transmission during the high viremic phase of PHI. This review focuses on prevalence, basic principles, diagnostic markers, and approaches for the treatment of PHI due to sexual transmission of drug-resistant HIV-1. The aim of the paper is to help clinicians to deal with patients presenting a PHI due to drug-resistant variants.
Sexual Health – CSIRO Publishing
Published: Sep 20, 2005
Keywords: HIV drug resistance, primary HIV infection, resistance mutations, transmission.
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.